Skip to content
Snippets Groups Projects
Commit 0625d380 authored by Liliana Sanfilippo's avatar Liliana Sanfilippo
Browse files

intro

parent c17dc29e
No related branches found
No related tags found
No related merge requests found
import { ButtonOne } from "../../components/Buttons"; import { ButtonOne } from "../../components/Buttons";
import { H5 } from "../../components/Headings"; import { H5 } from "../../components/Headings";
import { LoremMedium } from "../../components/Loremipsum"; import { LoremMedium } from "../../components/Loremipsum";
import PreCyse from "../../components/precyse";
import { BlockQuoteB } from "../../components/Quotes"; import { BlockQuoteB } from "../../components/Quotes";
import { Section } from "../../components/sections"; import { Section } from "../../components/sections";
...@@ -19,13 +20,76 @@ export function HPIntroduction(){ ...@@ -19,13 +20,76 @@ export function HPIntroduction(){
<ButtonOne openclass="intro-cycletab" text="Our Mission & Vision" open="mission"></ButtonOne> <ButtonOne openclass="intro-cycletab" text="Our Mission & Vision" open="mission"></ButtonOne>
</div> </div>
<div className="col"> <div className="col">
<ButtonOne openclass="intro-cycletab" text="Our Approach" open="approach"></ButtonOne>
</div>
<div className="col">
<ButtonOne openclass="intro-cycletab" text="Our Target Groups" open="targets"></ButtonOne> <ButtonOne openclass="intro-cycletab" text="Our Target Groups" open="targets"></ButtonOne>
</div> </div>
</div> </div>
<br/> <br/>
<div className="col intro-cycletab" id="understanding" style={{display: "block"}}> understanding <LoremMedium/> </div> <div className="col intro-cycletab" id="understanding" style={{display: "block"}}>
<div className="col intro-cycletab" id="mission" style={{display: "none"}}>mission <LoremMedium/> </div> <p>This year, we at iGEM Bielefeld-CeBiTec have consciously chosen a <b>human-centered project design</b>. At the heart of our iGEM project is
<div className="col intro-cycletab" id="targets" style={{display: "none"}}>targets <LoremMedium/> </div> one key pillar: <b>Human Practice</b>. Our goal is to understand the impact of our project on society, the scientific community and the world
as whole. This is not just about the technical effectiveness of our parts, but also about how the solution is embraced in everyday
practice, and the potential long-term impact it could have for cystic fibrosis patients and their families all over the world.
</p>
<p>With our human-centered approach, we aim to address fundamental iGEM Human Practice questions and beyond:
</p>
<p style={{textAlign: "center"}}> <b>How does our project affect the world around us?</b></p>
<p style={{textAlign: "center"}}> <b>How does the world around us influence our project? </b></p>
<p>From the very beginning, it was our priority to identify various stakeholders and meet people affected by cystic fibrosis early on to
<b>actively involve</b> them throughout the planning and development process. This collaborative approach allowed us to ensure that our project
addresses real needs and contributes to solutions for as many different people as possible. Without the critical advice, varied perspectives
and input from our stakeholders, it would have been impossible to identify and reflect on all aspects of our project. We made every
effort to <b>deeply understand</b> their values and backgrounds, allowing us to integrate their feedback into our solutions.
</p>
</div>
<div className="col intro-cycletab" id="mission" style={{display: "none"}}>
<p>We view Human Practice as an opportunity to <b>go beyond practical lab work and traditional science</b> and to learn about
the needs of people affected by cystic fibrosis. It’s a chance for us to creatively engage with different aspects of our project
while developing an awareness of the responsibilities that come with it.
</p>
<p>
As part of our <PreCyse/> project, we performed intensive brainstorming sessions and expert consultations. We conducted comprehensive
surveys[Link] among the public and people with cystic fibrosis and their relatives. We focused on critical aspects such as the <b>needs of our
target groups, safety, ethics, design, implementation, and business</b> — each guided by the core values of our team. Based on these interactions
and the recommendations of the Human Practice committee, we have developed an optimal strategy for our project, ensuring that our work is not
only innovative but also mindful of its broader impact on society.
</p>
</div>
<div className="col intro-cycletab" id="approach" style={{display: "none"}}>
<p>It was important to us as a team to not only offer technical solutions, but to show that our project can contribute to the larger context of ongoing initiatives and movements to optimize health care. We wanted to really understand the feedback and insights of the stakeholders to gain a better understanding of how our project fits into the overall picture of living with cystic fibrosis, the current state of research and how it can be used to reduce the health care gap.
</p>
<p>Our strategy includes:</p>
<ul>
<li>Identifying key target groups</li>
<li>Establishing meaningful and lasting communication with stakeholders</li>
<li>Effectively engaging with the diverse backgrounds of those involved</li>
<li>Understand the ethical, social and scientific values that inspired our project</li>
<li>Integrating feedback and adapting our approach to align with stakeholder goals</li>
<li>Designing and incorporating representative surveys</li>
<li>Reflect on how these values have been incorporated into our project</li>
</ul>
<p>With this approach and the support of our stakeholders, our ultimate goals are to:</p>
<ul>
<li>Improve care for cystic fibrosis patients</li>
<li>Optimize the availability of essential medications</li>
</ul>
</div>
<div className="col intro-cycletab" id="targets" style={{display: "none"}}>
<p>Our target groups are composed of <b>academic and clinical experts</b> to build a bridge between research and practical application.
In addition, engaging with CF <b>patients</b> across different age groups and countries and their relatives leads to an awareness of
the special needs and demands of our project and to an understanding of the limitations and challenges in everyday CF life. The
integration of regulatory ethics serves to evaluate how our project might be implemented in German and international <b>government</b>
regulations for gene therapeutics. The exchange with <b>companies</b> contributes to understanding the chances and challenges in business of
establishing a start-up and what it takes to get our idea on the market for real life application. The continuous exchange between the
different groups contributes significantly to the successful implementation of the project. First-hand information from our target groups
and the matching and merging of the information is therefore essential for defining and achieving our goals.
</p>
</div>
</Section> </Section>
) )
} }
\ No newline at end of file
0% Loading or .
You are about to add 0 people to the discussion. Proceed with caution.
Finish editing this message first!
Please register or to comment